Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health IT Workgroup’s Final Regulatory Recommendations Approved

This article was originally published in The Gray Sheet

Executive Summary

The final recommendations from the FDASIA workgroup urge the government to focus regulatory attention on the highest risk products, while minimizing requirements for the large swath of health IT offerings that are lower risk. The recommendations, which largely align with a prior draft version, will inform a health IT regulatory framework proposal due to Congress in January.


Related Content

mHealth Experts Call For App Review Organizations To Ensure Quality
McKesson Recall Dovetails With Broader Health IT Reg Debate
Health IT Reg Bill Sparks Debate; AdvaMed Tries To Address “Technical Concerns”
Health IT Deregulation Bill Introduced In Senate, With Powerful Industry Backers
mHealth Coalition Counters Blackburn Push Against Health IT Regs
Digital Health Briefs: New Health IT Chief, NIH Funding, Scripps Pilot
Digital Health Regulation Debate Continues At mHealth Summit
Representatives Grill Shuren, Advance SOFTWARE Act
Pending Mobile Medical Apps Guidance Provokes Heated Controversy
Workgroup Unveils Preliminary Health IT Regulation Proposals





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts